- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Pharmaceutical industry - number of new substances 1992-2018
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Pharmaceutical industry - number of new substances 1992-2018
Number of new chemical or biological entities developed between 1992 and 2018, by region of origin
by Matej Mikulic,
last edited
Aug 8, 2019
This statistic shows the number of new chemical or biological entities bought to the pharmaceutical industry in periods between 1998 and 2018, by region. In the period between 1998 and 2002, 29 new substances were introduced through Japanese companies.
Number of new chemical or biological entities developed between 1992 and 2018, by region of origin
| Nationality of mother company | 1998-2002 | 2003-2007 | 2008-2012 | 2013-2017 | 2014-2018 |
|---|---|---|---|---|---|
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| Nationality of mother company | 1998-2002 | 2003-2007 | 2008-2012 | 2013-2017 | 2014-2018 |
|---|---|---|---|---|---|
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
| - | - | - | - | - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Aug 8, 2019
This statistic shows the number of new chemical or biological entities bought to the pharmaceutical industry in periods between 1998 and 2018, by region. In the period between 1998 and 2002, 29 new substances were introduced through Japanese companies.
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- 2019
- Region
- Worldwide
- Survey time period
- 1997 to 2018
- Supplementary notes
-
EFPIA stands for the European Federation of Pharmaceutical Industries and Associations.
This statistic was assembled from several editions of this report. - Open this statistic in...
Source
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- 2019
More information
- Region
- Worldwide
- Survey time period
- 1997 to 2018
- Supplementary notes
-
EFPIA stands for the European Federation of Pharmaceutical Industries and Associations.
This statistic was assembled from several editions of this report. - Open this statistic in...
Other statistics on the topic
Global Pharmaceutical Industry
+Pharmaceutical Products & Market
2018 list of global top 10 biotech and pharmaceutical companies based on net income
+Pharmaceutical Products & Market
Total global pharmaceutical R&D spending 2010-2024
+Pharmaceutical Products & Market
World pharmaceutical sales 2016-2018 by region
+Pharmaceutical Products & Market
Top therapeutic classes by global pharmaceutical sales 2018 estimates
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Clinical trials
- 99 page/s
- English
- pptx
- Detailed references
Everything On "Clinical trials" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Other Reports & Dossiers
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Global pharmaceutical industry"
- Overview
The most important statistics
- Revenue of the worldwide pharmaceutical market from 2001 to 2018 (in billion U.S. dollars)Pharmaceutical market: worldwide revenue 2001-2018
- Distribution of global pharmaceutical market revenue from 2010 to 2018, by regionGlobal pharmaceutical market - revenue distribution 2010-2018, by region
- Global pharmaceutical sales from 2016 to 2018, by region (in billion U.S. dollars)*World pharmaceutical sales 2016-2018 by region
- Distribution of the total global pharmaceutical market sales from 2014 to 2018, by submarket*World pharmaceutical market distribution by submarket 2014-2018
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*Top 10 global pharmaceutical markets: growth 2012-2017
- Top 10 therapeutic classes by estimated global pharmaceutical sales in 2018 (in billion U.S. dollars)Top therapeutic classes by global pharmaceutical sales 2018 estimates
- Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018*Spending growth of top pharmaceutical therapeutic classes by CAGR 2014-2018
- Companies and products
The most important statistics
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
- 2018 ranking of the global top 10 biotech and pharmaceutical companies based on net income (in billion U.S. dollars)2018 list of global top 10 biotech and pharmaceutical companies based on net income
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2019 (in billion U.S. dollars)Top 10 biotech and pharmaceutical companies based on market cap 2019
- World's top 50 pharmaceutical and biotechnology companies based on capital expenditure growth in 2017/2018Top pharmaceutical companies by capex growth in 2017/2018
- Top 15 pharmaceutical products by sales worldwide in 2018 (in million U.S. dollars)Top pharmaceutical products by sales worldwide 2018
- Top generics manufacturers based on revenue in 2018 (in billion U.S. dollars)*Revenues of leading global generics manufacturers 2018
- Top 10 cancer drugs worldwide by revenue in 2018 (in billion U.S. dollars)Top cancer drugs based on revenue worldwide 2018
- Top companies by revenue
The most important statistics
- Pfizer's total revenue from 2006 to 2018 (in million U.S. dollars)Pfizer's total revenue 2006-2018
- Pfizer's revenue in 2014 and 2018, by segment (in million U.S. dollars)*Pfizer's revenue by segment 2014-2018
- Novartis AG's total revenue from 2007 to 2018 (in billion U.S. dollars)Novartis' revenue 2007-2018
- Novartis AG's revenue from 2014 to 2018, by segment (in billion U.S. dollars)Novartis revenue 2014-2018 by segment
- Total sales of the Roche Group from 2006 to 2018 (in million Swiss francs)Roche Group's total sales 2006-2018
- Total sales of the Roche Group from 2013 to 2018, by division (in million Swiss francs)Roche Group's total sales by division 2013-2018
- R&D, patents, new products
The most important statistics
- Total global spending on pharmaceutical research and development from 2010 to 2024 (in billion U.S. dollars)Total global pharmaceutical R&D spending 2010-2024
- Global top 10 pharmaceutical companies based on projected R&D spending in 2024 (in billion U.S. dollars)Global top pharmaceutical companies based on R&D spending 2024
- Worldwide total prescription drug revenue at risk from patent expiration from 2010 to 2024 (in billion U.S. dollars)*Patent expiration risks for total worldwide prescription drug revenue 2010-2024
- Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024Worldwide prescription drug revenue - market risk from patent expiration 2010-2024
- Small molecules sales at risk due to patent expirations in the U.S. from 2009 to 2022 (in billion U.S. dollars)Projected sales at risk due to patent expiry 2009-2022
- Number of new chemical or biological entities developed between 1992 and 2018, by region of originPharmaceutical industry - number of new substances 1992-2018
- Total number of novel drugs approved by CDER from 2008 to 2018Number of novel drugs approved annually by CDER 2008-2018
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)Projection of top 2018 pharma and biotech launches by revenue 2022
- Outlook
The most important statistics
- Projected global pharmaceutical sales for 2022, by region (in billion U.S. dollars)*World pharmaceutical sales by region forecast 2022
- Worldwide forecast of pharmaceutical sector growth between 2017 and 2030, by countryPharmaceutical sector growth worldwide 2017-2030, by country
- Global spending on medicines in 2010, 2018, and a forecast for 2023 (in billion U.S. dollars)Global spending on medicines 2010-2023
- Projected expenditure on medicine of selected countries worldwide in 2023 (in billion U.S. dollars)Country comparison in spending on medicine 2023
- Projected top 10 global pharmaceutical products by revenue in 2024 (in million U.S. dollars)Leading global pharmaceutical products and respective revenues 2024
- Global top 10 pharmaceutical companies based on projected R&D spending in 2024 (in billion U.S. dollars)Global top pharmaceutical companies based on R&D spending 2024
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Availability of new medicines in selected countries 2013
- Direct export value of biological product from Taiwan 2008-2017
- Small molecules facing loss of developed market exclusivity 2011-2020
- New medicine availability by therapy area in the U.S. 2013
- Pharmaceutical Industry: Origin of new molecular entities
- Production value of biological product in Taiwan 2008-2017
- Domestic sales value of biological product in Taiwan 2008-2017
- Top new orphan molecular entities by U.S. sales in 2019
- U.S. biological products ad spend 2010-2016
- Italy: turnover of chemical and pharmaceutical bio-based products 2015-2016
- Number of new psychoactive substance identified globally 2014
- Domestic demand of surface-active agents Japan 2012-2017
- Number of oncology NMEs launched by biologics and non-biologic 2004-2013
- Medication: availability of anti-migraine active ingredients globally 2011
- Muslim groups and spaces in Spain in 2018, by type
- Sales value of biological product in Taiwan 2008-2017
- Phytosanitary treatments in arboriculture in France 2015, by type of fruit
- U.S. biological products: ad spend to sales ratio 2011-2015
- Industry revenue of “Biological preparations“ in Japan 2011-2023
- Forecast: value of shipments biological product manufacture US 2008-2020
Studies
- Dechra Pharmaceuticals PLC Annual Report 2018
- Value and Innovation Framework Report 2019
- LEO Pharma A/S Annual Report 2017
- Antibiotic use in the United Kingdom (UK)
- Pharmaceutical industry in the Netherlands
- Medtronic - 2019 Form 10-K
- Novo Nordisk ANNUAL REPORT 2017
- Lundbeck Annual Report 2017
- Indicatori Farmaceutici
- Sobi Anual and sustainability report 2017
- The Changing Face of Global Clinical Trials
- Global Participation in Clinical Trials Report 2015-2016
- Overview of Korean Drug Research Association (KDRA), Korea Health Industry Development Ins...
- Diagnóstico Sectorial Farmacéutico
- Biopharmaceutical Industry-Sponsored Clinical Trials: Impact on State Economies
Statistics on "Global pharmaceutical industry"
- Revenue of the worldwide pharmaceutical market from 2001 to 2018 (in billion U.S. dollars)
- Distribution of global pharmaceutical market revenue from 2010 to 2018, by region
- Global pharmaceutical sales from 2016 to 2018, by region (in billion U.S. dollars)*
- Distribution of the total global pharmaceutical market sales from 2014 to 2018, by submarket*
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*
- Top 10 therapeutic classes by estimated global pharmaceutical sales in 2018 (in billion U.S. dollars)
- Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018*
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)
- 2018 ranking of the global top 10 biotech and pharmaceutical companies based on net income (in billion U.S. dollars)
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2019 (in billion U.S. dollars)
- World's top 50 pharmaceutical and biotechnology companies based on capital expenditure growth in 2017/2018
- Top 15 pharmaceutical products by sales worldwide in 2018 (in million U.S. dollars)
- Top generics manufacturers based on revenue in 2018 (in billion U.S. dollars)*
- Top 10 cancer drugs worldwide by revenue in 2018 (in billion U.S. dollars)
- Pfizer's total revenue from 2006 to 2018 (in million U.S. dollars)
- Pfizer's revenue in 2014 and 2018, by segment (in million U.S. dollars)*
- Novartis AG's total revenue from 2007 to 2018 (in billion U.S. dollars)
- Novartis AG's revenue from 2014 to 2018, by segment (in billion U.S. dollars)
- Total sales of the Roche Group from 2006 to 2018 (in million Swiss francs)
- Total sales of the Roche Group from 2013 to 2018, by division (in million Swiss francs)
- Total global spending on pharmaceutical research and development from 2010 to 2024 (in billion U.S. dollars)
- Global top 10 pharmaceutical companies based on projected R&D spending in 2024 (in billion U.S. dollars)
- Worldwide total prescription drug revenue at risk from patent expiration from 2010 to 2024 (in billion U.S. dollars)*
- Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024
- Small molecules sales at risk due to patent expirations in the U.S. from 2009 to 2022 (in billion U.S. dollars)
- Number of new chemical or biological entities developed between 1992 and 2018, by region of origin
- Total number of novel drugs approved by CDER from 2008 to 2018
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)
- Selected top pharmaceutical R&D projects based on net present value (NPV) as of May 2019 (in million U.S. dollars)
- Projected global pharmaceutical sales for 2022, by region (in billion U.S. dollars)*
- Worldwide forecast of pharmaceutical sector growth between 2017 and 2030, by country
- Global spending on medicines in 2010, 2018, and a forecast for 2023 (in billion U.S. dollars)
- Projected expenditure on medicine of selected countries worldwide in 2023 (in billion U.S. dollars)
- Projected top 10 global pharmaceutical products by revenue in 2024 (in million U.S. dollars)
- Global new molecular entities availability in selected countries in 2013*
- Direct export value of biological product from Taiwan between 2008 and 2017 (in million New Taiwan dollars)
- Loss through small molecule patent expiries in developed pharmaceutical markets from 2011 to 2020 (in billion U.S. dollars)
- New molecular entities availability in the United States as of 2013, by therapy area*
- Origin of the 25 new chemical and biological entities in the world pharmaceutical market in 2009
- Production value of biological product in Taiwan between 2008 and 2017 (in billion New Taiwan dollars)
- Domestic sales value of biological product in Taiwan between 2008 and 2017 (in million New Taiwan dollars)
- Leading new orphan molecular entities by U.S. sales in 2014 and 2019 (in million U.S. dollars)*
- Advertising spending in the biological products industry in the United States from 2010 to 2016 (in million U.S. dollars)
- Turnover of the sector of chemical and pharmaceutical bio-based products in Italy in 2015 and 2016 (in billion euros)
- Distribution of newly identified psychoactive substances worldwide by type in 2014
- Domestic demand of surface-active agents in Japan from 2012 to 2017 (in 1,000 tons)
- Number of new molecular entities for cancer launched worldwide from 2004 to 2013, by type
- Availability of anti-migraine medication worldwide in 2011, by active ingredient
- Number of Muslim entities, communities and cemeteries in Spain in 2018, by type
- Sales value of biological product in Taiwan between 2008 and 2017 (in billion New Taiwan dollars)
- Average number of phytosanitary treatments in arboriculture in France in 2015, by type of fruit*
- Advertising spending as percent of sales in the biological products industry in the United States from 2011 to 2015
- Industry revenue of “Biological preparations“ in Japan from 2011 to 2023 (in billion U.S. Dollars)
- Value of shipments of biological product manufacture (NAICS 325414) in United States from 2008 to 2020 (in million U.S. dollars)
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.